These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24222948)

  • 1. Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.
    Eslam M; Booth DR; George J; Ahlenstiel G
    World J Gastroenterol; 2013 Nov; 19(41):7055-61. PubMed ID: 24222948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
    Tillmann HL; Patel K; Muir AJ; Guy CD; Li JH; Lao XQ; Thompson A; Clark PJ; Gardner SD; McHutchison JG; McCarthy JJ
    J Hepatol; 2011 Dec; 55(6):1195-200. PubMed ID: 21703198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.
    Taliani G; Spaziante M; Biliotti E; Borro M; Palazzo D; Grieco S; Franchi C; Iaiani G; Furlan C; Gallinaro V; Simmaco M
    PLoS One; 2013; 8(8):e67301. PubMed ID: 23936294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
    Huang CM; Chang KC; Hung CH; Chiu KW; Lu SN; Wang JH; Chen CH; Kee KM; Kuo YH; Tsai MC; Tseng PL; Lin MT; Wu CK; Hu TH; Cho CL; Yen YH
    PLoS One; 2017; 12(8):e0182204. PubMed ID: 28797039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.
    Stättermayer AF; Rutter K; Beinhardt S; Scherzer TM; Stadlmayr A; Hofer H; Wrba F; Steindl-Munda P; Krebs M; Datz C; Trauner M; Ferenci P
    J Hepatol; 2012 Sep; 57(3):492-8. PubMed ID: 22634340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.
    Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E
    Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
    J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of
    Nakamoto S; Imazeki F; Kanda T; Wu S; Nakamura M; Yasui S; Tawada A; Mikata R; Chiba T; Arai M; Yokosuka O; Shirasawa H
    Int J Med Sci; 2017; 14(11):1088-1093. PubMed ID: 29104462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.
    Chiba-Falek O; Linnertz C; Guyton J; Gardner SD; Roses AD; McCarthy JJ; Patel K
    Hum Genet; 2012 Dec; 131(12):1911-20. PubMed ID: 22898894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients.
    Valenti L; Aghemo A; Stättermayer AF
    J Hepatol; 2012 May; 56(5):1209-1210. PubMed ID: 22230871
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection.
    Clark PJ; Thompson AJ; Zhu Q; Vock DM; Zhu M; Patel K; Harrison SA; Naggie S; Ge D; Tillmann HL; Urban TJ; Shianna K; Fellay J; Goodman Z; Noviello S; Pedicone LD; Afdhal N; Sulkowski M; Albrecht JK; Goldstein DB; McHutchison JG; Muir AJ
    Dig Dis Sci; 2012 Aug; 57(8):2213-21. PubMed ID: 22543885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
    Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
    Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
    Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
    Hui JM; Kench J; Farrell GC; Lin R; Samarasinghe D; Liddle C; Byth K; George J
    J Gastroenterol Hepatol; 2002 Aug; 17(8):873-81. PubMed ID: 12164963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
    Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
    J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable association between genetic polymorphisms near the IL28B gene and hepatic steatosis: direct or indirect?
    Toyoda H; Kumada T
    J Hepatol; 2012 Mar; 56(3):738-9; author reply 739. PubMed ID: 22340673
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population.
    Rauff B; Amar A; Chudhary SA; Mahmood S; Tayyab GUN; Hanif R
    Arch Virol; 2021 Apr; 166(4):1047-1056. PubMed ID: 33528661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.